Skip to main content

Table 1 Patient participant characteristics

From: Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

Patient code

Gender

Age group (years)

Treatment-taking profile at time of interview

Treatment history

P01

Female

20–29

Partially adherent

New pt (no prior tx history)

P02 & P02 FU

Female

20–29

LFT

Extensive (DS to DR)

P03 & P03 FU

Female

20–29

Partially adherent

Extensive (DS to DR)

P04

Male

20–29

Adherent

New pt (no prior tx history)

P05

Male

40–49

Adherent

Tx after LFT from SCR

P06

Male

20–29

Partially adherent

Previous incomplete DS tx

P07

Female

20–29

LFT

Previous incomplete DS tx

P08

Male

50–59

Partially adherent

Previous incomplete DS tx

P09

Female

20–29

Partially adherent

Previous incomplete DS tx

P10

Male

20–29

Adherent

New pt (no prior tx history)

P11

Female

20–29

Adherent

Relapse

P12

Female

60–69

Adherent

New pt (no prior tx history)

P13

Female

20–29

Adherent

New pt (no prior tx history)

P14

Female

20–29

Partially adherent

Relapse

P15

Male

30–39

Adherent

New pt (no prior tx history)

P16

Male

20–29

Partially adherent

New pt (no prior tx history)

P17

Male

40–49

Adherent

Extensive (DS to DR)

P18 & P18 FU

Female

20–29

Adherent

Extensive (DS to DR)

P19

Male

16–20

Partially adherent

New pt (no prior tx history)

P20

Male

20–29

Adherent

Relapse

P21

Male

20–29

Adherent

Relapse

P22

Male

20–29

Adherent

New pt (no prior tx history)

P23 & P23 FU

Male

16–20

Adherent

New pt (no prior tx history)

P24

Female

30–39

LFT

1 previous course (failure after amplification)

P25

Female

20–29

LFT

New pt (no prior tx history)

P26

Female

60–69

LFT

1 previous course (failure after amplification)

P27

Female

60–69

LFT

1 previous course

P28

Male

20–29

Partially adherent

Relapse

P29

Male

30–39

LFT

Relapse

P30

Female

30–39

Partially adherent

Unknown

P31

Female

20–29

Partially adherent

Unknown

P32

Male

30–39

LFT

2 previous courses

P33

Female

30–39

Partially adherent

New pt (no prior tx history)

P34

Female

30–39

Adherent

1 previous course

P35

Female

30–39

Adherent

2 previous courses

  1. FU follow-up interview, Tx treatment, Pt patient, LFT lost from treatment, DS drug sensitive, DR drug resistant, SCR short-course regimen (9 month MDR-TB treatment regimen being piloted)